Overview
PRCT market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
PRCT price chart · 1M
- O
- 20.02
- H
- 20.32
- L
- 19.44
- C
- 20.05
- Vol
- 18,327.00
Daily history from Sep 15, 2021
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $20.02
- Previous Close
- $20.27
- Day High
- $20.32
- Day Low
- $19.44
- 52 Week High
- $38.08
- 52 Week Low
- $16.67
- 7 Day Return
- +4.51%
- 30 Day Return
- +11.82%
- 90 Day Return
- -7.67%
- 1 Year Return
- -35.90%
- Daily Notional Volume
- $367.5K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.72 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.95 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -32.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.67 – $38.11 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.2B · P/B 4.80 · P/S 3.68.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
PROCEPT BioRobotics Q3 EPS $(0.46) Misses $(0.38) Estimate, Sales $98.291M Miss $102.563M EstimateBenzinga ·
8-K filing — PROCEPT BioRobotics Corp (PRCT)SEC EDGAR ·